Inventor · disambiguated record
Mao Mao
6 granted patents·19 pending applications·483 citations·filing 2001–2022
86Inventor score
Files withROSETTA INPHARMATICS LLC4SEEKIN INC4DAI HONGYUE2NETHERLANDS CANCER INST2THE NETHERLANDS CANCER INST2
Top patents by PatentIndex Score
25 records- 0196US7514209B2Diagnosis and prognosis of breast cancer patientsROSETTA INPHARMATICS LLC·Filed 2002·Granted Apr 7, 2009·139 cites·44 claims
- 0295US7171311B2Methods of assigning treatment to breast cancer patientsNETHERLANDS CANCER INST·Filed 2003·Granted Jan 30, 2007·289 cites·33 claims
- 0393US8014957B2Genes associated with progression and response in chronic myeloid leukemia and uses thereofHUTCHINSON FRED CANCER RES·Filed 2006·Granted Sep 6, 2011·46 cites·16 claims
- 0484US7863001B2Diagnosis and prognosis of breast cancer patientsNETHERLANDS CANCER INST·Filed 2008·Granted Jan 4, 2011·7 cites·9 claims
- 0573US9909185B2Diagnosis and prognosis of breast cancer patientsTHE NETHERLANDS CANCER INST·Filed 2012·Granted Mar 6, 2018·2 cites·16 claims
- 0661US2018305768A1Diagnosis and prognosis of breast cancer patientsTHE NETHERLANDS CANCER INST·Filed 2018·Application pending·0 cites
- 0756US2007134660A1Methods for identifying modulators of kinesin activityMERCK & CO INC·Filed 2004·Application pending·0 cites
- 0855US2023079748A1Preparation method, product, and application of circulating tumor dna reference samplesSEEKIN INC·Filed 2022·Application pending·0 cites
- 0952US2024023360A1Color-tunable oled having long operational lifetimeUNIV HONG KONG·Filed 2021·Application pending·0 cites
- 1052US2012072124A1Genes associated with progression and response in chronic myeloid leukemia and uses thereofRADICH JERALD P·Filed 2011·Application pending·0 cites
- 1152US2021207229A1Hepatocellular carcinoma screeningSEEKLN INC·Filed 2019·Application pending·0 cites
- 1251US2004023276A1LXR-ligand induced genes and proteinsFiled 2003·Application pending·0 cites
- 1351US2021217493A1Reducing noise in sequencing dataSEEKIN INC·Filed 2019·Application pending·0 cites
- 1451US2005054826A1Human diaphanous-3 gene and methods of use thereforROSETTA INPHARMATICS LLC·Filed 2004·Application pending·0 cites
- 1551US2006292623A1Signature genes in chronic myelogenous leukemiaROSETTA INPHARMATICS LLC·Filed 2006·Application pending·0 cites
- 1650US2023332238A1Method for cancer screening using capillary blood sampleSEEKIN INC·Filed 2022·Application pending·0 cites
- 1749US2011301048A1Diagnosis and prognosis of breast cancer patientsDAI HONGYUE·Filed 2010·Application pending·0 cites
- 1847US2003119024A1Genes and proteins associated with T cell activationFiled 2002·Application pending·0 cites
- 1944US2003104426A1Signature genes in chronic myelogenous leukemiaFiled 2002·Application pending·0 cites
- 2043US2005181385A1Synthetic lethal screen using RNA interferenceFiled 2004·Application pending·0 cites
- 2142US11958870B2Spiro-containing platinum(II) emitters with tunable emission energies and syntheses thereofUNIV HONG KONG·Filed 2019·Granted Apr 16, 2024·0 cites·17 claims
- 2241US2009004645A1Methods for Identifying Genes that Mediate a Response of a Living Cell to an AgentROSETTA INPHARMATICS LLC·Filed 2005·Application pending·0 cites
- 2341US2002019520A1CBFBGA09: a human SL15 homologFiled 2001·Application pending·0 cites
- 2438US2022136062A1Method for predicting cancer risk value based on multi-omics and multidimensional plasma features and artificial intelligenceSEEKIN INC·Filed 2021·Application pending·0 cites
- 2537US2009239214A1Prognosis of breast cancer patientsDAI HONGYUE·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mao Mao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →